Cello Group Plc
| London Stock Exchange: CLL
Cello Group Plc is a global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors. It operates through two divisions: Cello Health and Cello Consumer. The Cello Health Division provides market research, consulting and communications services principally to its pharmaceutical and healthcare clients. The Cello Consumer Division provides market research and direct communications services principally to its consumer facing clients. The company was founded by Mark Coleridge Scott and Kevin Barrie Steeds on May 5, 2004 and is headquartered in London, the United Kingdom.